Cover Image
Market Research Report
Product code 
1039004

Eubiotics Market Size By Product, By Form, By Application, By Livestock, Regional Outlook Competitive Market Share & Forecast, 2020 - 2026

Published: | Global Market Insights Inc. | 420 Pages | Delivery time: 2-3 business days

Price

Back to Top
Eubiotics Market Size By Product, By Form, By Application, By Livestock, Regional Outlook Competitive Market Share & Forecast, 2020 - 2026
Published: November 30, 2021
Global Market Insights Inc.
Content info: 420 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents

The eubiotics market is expected to register significant growth by 2027 due to rising prevalence of livestock diseases worldwide.

Eubiotics are a type of feed additive added to animal feed to ensure gut integrity in livestock. This class of feed additives includes organic acids, probiotics, essential oils, prebiotics, and polyphenols. The ongoing shift towards maintaining the healthy functioning of the digestive system of animals under commercial production without using antibiotics has boosted industry uptake in recent years.

Moreover, recent studies indicate that the use of eubiotic feed additives into milk replacer has been shown to improve dairy calves' rumen fermentation, health, biochemical blood indicators, and performance during the preweaning period. Recently, mounting demand for animal products, such as meat, milk, and eggs, has fostered market expansion.

The eubiotics market has been bifurcated based on livestock, product, application, form, and region. In terms of product, the market has further been divided into exogenous enzymes, prebiotics, essential oils, probiotics, and organic acid. Under prebiotics, the market has been categorized into galacto-oligosaccharide (GOS), inulin, fructo-oligosaccharide (FOS), mannan-oligosaccharide (MOS), and others.

The inulin segment is set to register over 10.0% gains by the end of 2027. The fructo-oligosaccharide (FOS) segment is projected to expand at a CAGR of above 10.3% over the forecast period. The mannan-oligosaccharide (MOS) segment is speculated to grow at approximately 10.5% CAGR through the stipulated period. Meanwhile, the galacto-oligosaccharide (GOS) segment is expected to reach a valuation of about USD 21.5 million by the end of 2027.

The probiotics segment is estimated to surpass USD 450 million in revenue by 2027 on account of mounting adoption of probiotics in poultry and swine nutrition. Under probiotics, the market has been segmented into Streptococcus, Lactobacillus, Bacillus, Bifidobacterium, and others.

The Lactobacillus segment is expected to attain a valuation of around USD 305 million by the end of 2027. The Bifidobacterium segment is calculated to register 7.3% gains by 2027. The Bacillus segment is speculated to progress at about 8.8% CAGR over the analysis timeframe. Meanwhile, the Streptococcus segment is slated to garner above 9.0% gains by 2027.

Under organic acids, the market has further been classified into propionic acid, acetic acid, formic acid, lactic acid, fumaric acid, and others. In 2020, the acetic acid segment accounted for about 3% market share and is projected to grow at a steady pace over 2021-2027. The lactic acid segment is anticipated to exhibit notable growth at approximately 8.9% CAGR through the study timeline.

The essential oils segment is poised to exceed a valuation USD 465 million by the end of 2027. Prevalent use of natural ingredients in animal feed products is slated to bolster segmental development in the forthcoming years.

Under exogenous enzymes, the market has been segregated into B-glucanase, amylase, protease, xylanases, and phytase. The xylanases segment is likely to be worth more than USD 285 million in revenue by 2027. The B-glucanase segment is slated to witness robust growth at a CAGR of around 10.4% over the assessment period.

From the application spectrum, the eubiotics market has been segregated into immunity, gut health, yield, and others. The others application segment is expected to grow at nearly 7.0% CAGR over the forecast period. Eubiotics help in balancing microflora in the gastrointestinal tract of the livestock, which promotes the growth performance of animals.

With respect to livestock, the eubiotics market has been bifurcated into aquaculture, poultry, cattle, swine, and others. The aquaculture segment is anticipated to be valued at over USD 300 million by 2027 due to the booming aquaculture industry in China, India, and Japan, among others. The others livestock segment is speculated to garner a valuation of around USD 860 million by 2027 owing to increasing focus towards improving the overall health and growth performance of animals. Other livestock include sheep and horses.

From the regional perspective, the Latin America eubiotics market is set to exceed a valuation of USD 860 million by 2027 on account of growing livestock farming and meat export in Brazil. The Middle East and Africa eubiotics industry is projected to expand at a CAGR of approximately 9.0% through the review period driven by surging demand for high-quality meat and meat products in the MEA region.

Product Code: 457

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates & working
    • 1.2.1 Forecast calculations
  • 1.3 Data Sources
    • 1.3.1 Primary
    • 1.3.2 Secondary
      • 1.3.2.1 Paid Sources
      • 1.3.2.2 Public Sources

Chapter 2 Executive Summary

  • 2.1 Eubiotics industry 360 degree synopsis, 2016 - 2027
    • 2.1.1 Business Trends
    • 2.1.2 Regional Trends
    • 2.1.3 Product Trends
    • 2.1.4 Form Trends
    • 2.1.5 Livestock Trends
    • 2.1.6 Application Trends

Chapter 3 Eubiotics Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry ecosystem analysis
    • 3.2.1 Vendor matrix
    • 3.2.2 Distribution channel analysis
      • 3.2.2.1 Collaboration/Partnerships
      • 3.2.2.2 Service Providers
      • 3.2.2.3 Contract Manufacturing
      • 3.2.2.4 Technology Providers
    • 3.2.3 Impact of COVID-19 on supply chain & raw material procurement
  • 3.3 Regulatory landscape
    • 3.3.1 U.S.
    • 3.3.2 Canada
    • 3.3.3 Europe
    • 3.3.4 China
  • 3.4 Pricing analysis, COVID-19 Impact
    • 3.4.1 Regional pricing
      • 3.4.1.1 Prebiotic pricing analysis
      • 3.4.1.2 Probiotics pricing analysis
      • 3.4.1.3 Organic acids pricing analysis
      • 3.4.1.4 Essential oil pricing analysis
      • 3.4.1.5 Exogeneous enzymes pricing analysis
    • 3.4.2 Cost structure analysis
  • 3.5 Technology landscape
    • 3.5.1 Probiotic manufacturing process
    • 3.5.2 Prebiotic manufacturing process
    • 3.5.3 Essential Oil Technology Landscape
    • 3.5.4 Organic Acid Technological Landscape
    • 3.5.5 Exogeneous enzymes
      • 3.5.5.1 Multi enzyme combination of amylase, protease and xylanase to improve performance in gut health
      • 3.5.5.2 Gut microbiota balance - DuPont Study
      • 3.5.5.3 Biotechnology application in improving livestock productivity
      • 3.5.5.4 Alterion Technology
      • 3.5.5.5 Effects of Bacillus subtilis strains on immunity, performance and livestock gut health
      • 3.5.5.6 Multi - Carbohydrate technology delivering higher nutritional extraction from wide arena of animal feed products
  • 3.6 Comparison
    • 3.6.1 Prebiotics vs Probiotics
  • 3.7 Industry impact forces
    • 3.7.1 Growth drivers
      • 3.7.1.1 Increases consumption of meat in Asia Pacific
      • 3.7.1.2 Antibiotics ban in Europe and U.S.
      • 3.7.1.3 Emerging livestock diseases
    • 3.7.2 Industry pitfalls & challenges
      • 3.7.2.1 Standardization issue
      • 3.7.2.2 Lack of systematic evaluation
  • 3.8 Innovation & sustainability
    • 3.8.1 Bio-catalysis for sustainable chemistry
    • 3.8.2 DNA diagnostics
  • 3.9 Growth potential analysis, 2020
    • 3.9.1 Emerging business model
      • 3.9.1.1 Collaboration/Joint ventures
      • 3.9.1.2 Acquisitions
      • 3.9.1.3 New product launches
  • 3.10 Porter's analysis
    • 3.10.1 Bargaining power of suppliers
    • 3.10.2 Bargaining power of buyers
    • 3.10.3 Threat of new entrants
    • 3.10.4 Threat of substitutes
  • 3.11 Competitive landscape, 2020
    • 3.11.1 Company Market share analysis, 2020
    • 3.11.2 Strategic dashboard
  • 3.12 PESTEL analysis
  • 3.13 COVID-19 impact on eubiotics market, by application
    • 3.13.1 Animal feed
      • 3.13.1.1 Poultry
      • 3.13.1.2 Swine
      • 3.13.1.3 Cattle
      • 3.13.1.4 Aquaculture
      • 3.13.1.5 Others
  • 3.14 Overview of COVID-19 impact on world economy
    • 3.14.1 COVID-19 impact on consumer buying behaviour
      • 3.14.1.1 Proactive health-minded buying
      • 3.14.1.2 Reactive health management
      • 3.14.1.3 Pantry preparation
      • 3.14.1.4 Quarantined living preparation
      • 3.14.1.5 Novel shopping practice
  • 3.15 Key success factors of the eubiotics market
    • 3.15.1 Unmet customer needs
      • 3.15.1.1 Continuous demand fulfilment (B2B)
      • 3.15.1.2 Quality & efficacy
    • 3.15.2 Efficient distribution channel/supply chain
      • 3.15.2.1 Distribution of ingredients/products to the end-use manufacturers/consumers
    • 3.15.3 Marketing challenges
    • 3.15.4 Cash flow protection & liquidity
      • 3.15.4.1 Short term financial obligations
      • 3.15.4.2 Long term financial obligations
    • 3.15.5 Product penetration pricing
    • 3.15.6 Innovation challenges

Chapter 4 Eubiotics Market, By Product

  • 4.1 Key product trends
  • 4.2 Prebiotics
    • 4.2.1 Global prebiotics market, 2016 - 2027
    • 4.2.2 Global prebiotics market, by region, 2016 - 2027
    • 4.2.3 Global prebiotics market, by ingredients, 2016 - 2027
      • 4.2.3.1 Inulin
        • 4.2.3.1.1 Global inulin market, 2016 - 2027
        • 4.2.3.1.2 Global inulin market, by region, 2016 - 2027
      • 4.2.3.2 Fructo-Oligosaccharide (FOS)
        • 4.2.3.2.1 Global FOS market, 2016 - 2027
        • 4.2.3.2.2 Global FOS market, by region, 2016 - 2027
      • 4.2.3.3 Mannan-Oligosaccharide (MOS)
        • 4.2.3.3.1 Global MOS market, 2016 - 2027
        • 4.2.3.3.2 Global FOS market, by region, 2016 - 2027
      • 4.2.3.4 Galacto-Oligosaccharide (GOS)
        • 4.2.3.4.1 Global GOS market, 2016 - 2027
        • 4.2.3.4.2 Global GOS market, by region, 2016 - 2027
      • 4.2.3.5 Others
        • 4.2.3.5.1 Global other prebiotic ingredients market, 2016 - 2027
        • 4.2.3.5.2 Global other prebiotic ingredients market, by region, 2016 - 2027
  • 4.3 Probiotics
    • 4.3.1 Global probiotics market, 2016 - 2027
    • 4.3.2 Global probiotics market, by region, 2016 - 2027
    • 4.3.3 Global probiotics market, by ingredients, 2016 - 2027
      • 4.3.3.1 Lactobacillus
        • 4.3.3.1.1 Global lactobacillus market, 2016 - 2027
        • 4.3.3.1.2 Global lactobacillus market, by region, 2016 - 2027
      • 4.3.3.2 Bifidobacterium
        • 4.3.3.2.1 Global bifidobacterium market, 2016 - 2027
        • 4.3.3.2.2 Global bifidobacterium market, by region, 2016 - 2027
      • 4.3.3.3 Bacillus
        • 4.3.3.3.1 Global bacillus market, 2016 - 2027
        • 4.3.3.3.2 Global bacillus market, by region, 2016 - 2027
      • 4.3.3.4 Streptococcus
        • 4.3.3.4.1 Global streptococcus market, 2016 - 2027
        • 4.3.3.4.2 Global streptococcus market, by region, 2016 - 2027
      • 4.3.3.5 Others
        • 4.3.3.5.1 Global other probiotic ingredients market, 2016 - 2027
        • 4.3.3.5.2 Global other probiotic ingredients market, by region, 2016 - 2027
  • 4.4 Organic acids
    • 4.4.1 Global organic acids market, 2016 - 2027
    • 4.4.2 Global organic acids market, by region, 2016 - 2027
    • 4.4.3 Global organic acids market, by product, 2016 - 2027
      • 4.4.3.1 Acetic acid
        • 4.4.3.1.1 Global acetic acid market, 2016 - 2027
        • 4.4.3.1.2 Global acetic acid market, by region, 2016 - 2027
      • 4.4.3.2 Lactic acid
        • 4.4.3.2.1 Global lactic acid market, 2016 - 2027
        • 4.4.3.2.2 Global lactic acid market, by region, 2016 - 2027
      • 4.4.3.3 Fumaric acid
        • 4.4.3.3.1 Global fumaric acid market, 2016 - 2027
        • 4.4.3.3.2 Global fumaric acid market, by region, 2016 - 2027
      • 4.4.3.4 Formic acid
        • 4.4.3.4.1 Global formic acid market, 2016 - 2027
        • 4.4.3.4.2 Global formic acid market, by region, 2016 - 2027
      • 4.4.3.5 Propionic acid
        • 4.4.3.5.1 Global propionic acid market, 2016 - 2027
        • 4.4.3.5.2 Global propionic acid market, by region, 2016 - 2027
      • 4.4.3.6 Others
        • 4.4.3.6.1 Global other organic acids acid market, 2016 - 2027
        • 4.4.3.6.2 Global other organic acids acid market, by region, 2016 - 2027
  • 4.5 Essential oils
    • 4.5.1 Global essential oils market, 2016 - 2027 (Kilo Tons) (USD Million)
    • 4.5.2 Global essential oils market, by region, 2016 - 2027 (Kilo Tons) (USD Million)
  • 4.6 Exogeneous enzymes
    • 4.6.1 Global exogeneous enzymes market, 2016 - 2027
    • 4.6.2 Global exogeneous enzymes market, by region, 2016 - 2027
    • 4.6.3 Global exogeneous enzymes market, by product, 2016 - 2027
      • 4.6.3.1 Amylase
        • 4.6.3.1.1 Global amylase market, 2016 - 2027
        • 4.6.3.1.2 Global amylase market, by region, 2016 - 2027
      • 4.6.3.2 Protease
        • 4.6.3.2.1 Global protease market, 2016 - 2027
        • 4.6.3.2.2 Global protease market, by region, 2016 - 2027
      • 4.6.3.3 Phytase
        • 4.6.3.3.1 Global phytase market, 2016 - 2027
        • 4.6.3.3.2 Global phytase market, by region, 2016 - 2027
      • 4.6.3.4 Xylanases
        • 4.6.3.4.1 Global xylanases market, 2016 - 2027
        • 4.6.3.4.2 Global xylanases market, by region, 2016 - 2027
      • 4.6.3.5 B-glucanase
        • 4.6.3.5.1 Global B-glucanase market, 2016 - 2027
        • 4.6.3.5.2 Global B-glucanase market, by region, 2016 - 2027

Chapter 5 Eubiotics Market, By Form

  • 5.1 Key form trends
  • 5.2 Dry form
    • 5.2.1 Global dry form eubiotics market, 2016 - 2027 (Kilo Tons) (USD Million)
    • 5.2.2 Global dry form eubiotics market, by region, 2016 - 2027 (Kilo Tons) (USD Million)
  • 5.3 Liquid form
    • 5.3.1 Global liquid form eubiotics market, 2016 - 2027 (Kilo Tons) (USD Million)
    • 5.3.2 Global liquid form eubiotics market, by region, 2016 - 2027 (Kilo Tons) (USD Million)

Chapter 6 Eubiotics Market, By Application

  • 6.1 Key application trends
  • 6.2 Gut health
    • 6.2.1 Global eubiotics market from gut health, 2016 - 2027, (Kilo Tons) (USD Million)
    • 6.2.2 Global eubiotics market from gut health, by region, 2016 - 2027 (Kilo Tons) (USD Million)
  • 6.3 Yield
    • 6.3.1 Global eubiotics market from yield, 2016 - 2027, (Kilo Tons) (USD Million)
    • 6.3.2 Global eubiotics market from yield, by region, 2016 - 2027 (Kilo Tons) (USD Million)
  • 6.4 Immunity
    • 6.4.1 Global eubiotics market from immunity, 2016 - 2027, (Kilo Tons) (USD Million)
    • 6.4.2 Global eubiotics market from immunity, by region, 2016 - 2027 (Kilo Tons) (USD Million)
  • 6.5 Others
    • 6.5.1 Global eubiotics market from other applications, 2016 - 2027, (Kilo Tons) (USD Million)
    • 6.5.2 Global eubiotics market from other applications, by region, 2016 - 2027 (Kilo Tons) (USD Million)

Chapter 7 Eubiotics Market, By Livestock

  • 7.1 Key livestock trends
  • 7.2 Poultry
    • 7.2.1 Global eubiotics market from poultry, 2016 - 2027, (Kilo Tons) (USD Million)
    • 7.2.2 Global eubiotics market from poultry, by region, 2016 - 2027, (Kilo Tons) (USD Million)
  • 7.3 Swine
    • 7.3.1 Global eubiotics market from swine, 2016 - 2027, (Kilo Tons) (USD Million)
    • 7.3.2 Global eubiotics market from swine, by region, 2016 - 2027, (Kilo Tons) (USD Million)
  • 7.4 Cattle
    • 7.4.1 Global eubiotics market from cattle, 2016 - 2027, (Kilo Tons) (USD Million)
    • 7.4.2 Global eubiotics market from cattle, by region, 2016 - 2027, (Kilo Tons) (USD Million)
  • 7.5 Aquaculture
    • 7.5.1 Global eubiotics market from aquaculture, 2016 - 2027, (Kilo Tons) (USD Million)
    • 7.5.2 Global eubiotics market from aquaculture, by region, 2016 - 2027, (Kilo Tons) (USD Million)
  • 7.6 Other
    • 7.6.1 Global eubiotics market from other livestock, 2016 - 2027, (Kilo Tons) (USD Million)
    • 7.6.2 Global eubiotics market from other livestock, by region, 2016 - 2027, (Kilo Tons) (USD Million)

Chapter 8 Eubiotics Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 North America eubiotics market, 2016 - 2027
    • 8.2.2 North America eubiotics market, by product, 2016 - 2027
    • 8.2.3 North America eubiotics market, by form, 2016 - 2027
    • 8.2.4 North America eubiotics market, by application, 2016 - 2027
    • 8.2.5 North America eubiotics market, by livestock, 2016 - 2027
    • 8.2.6 U.S.
      • 8.2.6.1 U.S. eubiotics market, 2016 - 2027
      • 8.2.6.2 U.S. eubiotics market, by product, 2016 - 2027
      • 8.2.6.3 U.S. eubiotics market, by form, 2016 - 2027
      • 8.2.6.4 U.S. eubiotics market, by application, 2016 - 2027
      • 8.2.6.5 U.S. eubiotics market, by livestock, 2016 - 2027
    • 8.2.7 Canada
      • 8.2.7.1 Canada eubiotics market, 2016 - 2027
      • 8.2.7.2 Canada eubiotics market, by product, 2016 - 2027
      • 8.2.7.3 Canada eubiotics market, by form, 2016 - 2027
      • 8.2.7.4 Canada eubiotics market, by application, 2016 - 2027
      • 8.2.7.5 Canada eubiotics market, by livestock, 2016 - 2027
    • 8.2.8 Mexico
      • 8.2.8.1 Mexico eubiotics market, 2016 - 2027
      • 8.2.8.2 Mexico eubiotics market, by product, 2016 - 2027
      • 8.2.8.3 Mexico eubiotics market, by form, 2016 - 2027
      • 8.2.8.4 Mexico eubiotics market, by application, 2016 - 2027
      • 8.2.8.5 Mexico eubiotics market, by livestock, 2016 - 2027
  • 8.3 Europe
    • 8.3.1 Europe eubiotics market, 2016 - 2027
    • 8.3.2 Europe eubiotics market, by product, 2016 - 2027
    • 8.3.3 Europe eubiotics market, by form, 2016 - 2027
    • 8.3.4 Europe eubiotics market, by application, 2016 - 2027
    • 8.3.5 Europe eubiotics market, by livestock, 2016 - 2027
    • 8.3.6 UK
      • 8.3.6.1 UK eubiotics market, 2016 - 2027
      • 8.3.6.2 UK eubiotics market, by product, 2016 - 2027
      • 8.3.6.3 UK eubiotics market, by form, 2016 - 2027
      • 8.3.6.4 UK eubiotics market, by application, 2016 - 2027
      • 8.3.6.5 UK eubiotics market, by livestock, 2016 - 2027
    • 8.3.7 Germany
      • 8.3.7.1 Germany eubiotics market, 2016 - 2027
      • 8.3.7.2 Germany eubiotics market, by product, 2016 - 2027
      • 8.3.7.3 Germany eubiotics market, by form, 2016 - 2027
      • 8.3.7.4 Germany eubiotics market, by application, 2016 - 2027
      • 8.3.7.5 Germany eubiotics market, by livestock, 2016 - 2027
    • 8.3.8 France
      • 8.3.8.1 France eubiotics market, 2016 - 2027
      • 8.3.8.2 France eubiotics market, by product, 2016 - 2027
      • 8.3.8.3 France eubiotics market, by form, 2016 - 2027
      • 8.3.8.4 France eubiotics market, by application, 2016 - 2027
      • 8.3.8.5 France eubiotics market, by livestock, 2016 - 2027
    • 8.3.9 Italy
      • 8.3.9.1 Italy eubiotics market, 2016 - 2027
      • 8.3.9.2 Italy eubiotics market, by product, 2016 - 2027
      • 8.3.9.3 Italy eubiotics market, by form, 2016 - 2027
      • 8.3.9.4 Italy eubiotics market, by application, 2016 - 2027
      • 8.3.9.5 Italy eubiotics market, by livestock, 2016 - 2027
    • 8.3.10 Russia
      • 8.3.10.1 Russia eubiotics market, 2016 - 2027
      • 8.3.10.2 Russia eubiotics market, by product, 2016 - 2027
      • 8.3.10.3 Russia eubiotics market, by form, 2016 - 2027
      • 8.3.10.4 Russia eubiotics market, by application, 2016 - 2027
      • 8.3.10.5 Russia eubiotics market, by livestock, 2016 - 2027
    • 8.3.11 Spain
      • 8.3.11.1 Spain eubiotics market, 2016 - 2027
      • 8.3.11.2 Spain eubiotics market, by product, 2016 - 2027
      • 8.3.11.3 Spain eubiotics market, by form, 2016 - 2027
      • 8.3.11.4 Spain eubiotics market, by application, 2016 - 2027
      • 8.3.11.5 Spain eubiotics market, by livestock, 2016 - 2027
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific eubiotics market, 2016 - 2027
    • 8.4.2 Asia Pacific eubiotics market, by product, 2016 - 2027
    • 8.4.3 Asia Pacific eubiotics market, by form, 2016 - 2027
    • 8.4.4 Asia Pacific eubiotics market, by application, 2016 - 2027
    • 8.4.5 Asia Pacific eubiotics market, by livestock, 2016 - 2027
    • 8.4.6 China
      • 8.4.6.1 China eubiotics market, 2016 - 2027
      • 8.4.6.2 China eubiotics market, by product, 2016 - 2027
      • 8.4.6.3 China eubiotics market, by form, 2016 - 2027
      • 8.4.6.4 China eubiotics market, by application, 2016 - 2027
      • 8.4.6.5 China eubiotics market, by livestock, 2016 - 2027
    • 8.4.7 India
      • 8.4.7.1 India eubiotics market, 2016 - 2027
      • 8.4.7.2 India eubiotics market, by product, 2016 - 2027
      • 8.4.7.3 India eubiotics market, by form, 2016 - 2027
      • 8.4.7.4 India eubiotics market, by application, 2016 - 2027
      • 8.4.7.5 India eubiotics market, by livestock, 2016 - 2027
    • 8.4.8 Japan
      • 8.4.8.1 Japan eubiotics market, 2016 - 2027
      • 8.4.8.2 Japan eubiotics market, by product, 2016 - 2027
      • 8.4.8.3 Japan eubiotics market, by form, 2016 - 2027
      • 8.4.8.4 Japan eubiotics market, by application, 2016 - 2027
      • 8.4.8.5 Japan eubiotics market, by livestock, 2016 - 2027
    • 8.4.9 Thailand
      • 8.4.9.1 Thailand eubiotics market, 2016 - 2027
      • 8.4.9.2 Thailand eubiotics market, by product, 2016 - 2027
      • 8.4.9.3 Thailand eubiotics market, by form, 2016 - 2027
      • 8.4.9.4 Thailand eubiotics market, by application, 2016 - 2027
      • 8.4.9.5 Thailand eubiotics market, by livestock, 2016 - 2027
    • 8.4.10 Malaysia
      • 8.4.10.1 Malaysia eubiotics market, 2016 - 2027
      • 8.4.10.2 Malaysia eubiotics market, by product, 2016 - 2027
      • 8.4.10.3 Malaysia eubiotics market, by form, 2016 - 2027
      • 8.4.10.4 Malaysia eubiotics market, by application, 2016 - 2027
      • 8.4.10.5 Malaysia eubiotics market, by livestock, 2016 - 2027
    • 8.4.11 Australia
      • 8.4.11.1 Australia eubiotics market, 2016 - 2027
      • 8.4.11.2 Australia eubiotics market, by product, 2016 - 2027
      • 8.4.11.3 Australia eubiotics market, by form, 2016 - 2027
      • 8.4.11.4 Australia eubiotics market, by application, 2016 - 2027
      • 8.4.11.5 Australia eubiotics market, by livestock, 2016 - 2027
    • 8.4.12 South Korea
      • 8.4.12.1 South Korea eubiotics market, 2016 - 2027
      • 8.4.12.2 South Korea eubiotics market, by product, 2016 - 2027
      • 8.4.12.3 South Korea eubiotics market, by form, 2016 - 2027
      • 8.4.12.4 South Korea eubiotics market, by application, 2016 - 2027
      • 8.4.12.5 South Korea eubiotics market, by livestock, 2016 - 2027
  • 8.5 Latin America (LATAM)
    • 8.5.1 LATAM eubiotics market, 2016 - 2027
    • 8.5.2 LATAM eubiotics market, by product, 2016 - 2027
    • 8.5.3 LATAM eubiotics market, by form, 2016 - 2027
    • 8.5.4 LATAM eubiotics market, by application, 2016 - 2027
    • 8.5.5 LATAM eubiotics market, by livestock, 2016 - 2027
    • 8.5.6 Brazil
      • 8.5.6.1 Brazil eubiotics market, 2016 - 2027
      • 8.5.6.2 Brazil eubiotics market, by product, 2016 - 2027
      • 8.5.6.3 Brazil eubiotics market, by form, 2016 - 2027
      • 8.5.6.4 Brazil eubiotics market, by application, 2016 - 2027
      • 8.5.6.5 Brazil eubiotics market, by livestock, 2016 - 2027
  • 8.6 Middle East & Africa (MEA)
    • 8.6.1 MEA eubiotics market, 2016 - 2027
    • 8.6.2 MEA eubiotics market, by product, 2016 - 2027
    • 8.6.3 MEA eubiotics market, by form, 2016 - 2027
    • 8.6.4 MEA eubiotics market, by application, 2016 - 2027
    • 8.6.5 MEA eubiotics market, by livestock, 2016 - 2027
    • 8.6.6 South Africa
      • 8.6.6.1 South Africa eubiotics market, 2016 - 2027
      • 8.6.6.2 South Africa eubiotics market, by product, 2016 - 2027
      • 8.6.6.3 South Africa eubiotics market, by form, 2016 - 2027
      • 8.6.6.4 South Africa eubiotics market, by application, 2016 - 2027
      • 8.6.6.5 South Africa eubiotics market, by livestock, 2016 - 2027
    • 8.6.7 Saudi Arabia
      • 8.6.7.1 Saudi Arabia eubiotics market, 2016 - 2027
      • 8.6.7.2 Saudi Arabia eubiotics market, by product, 2016 - 2027
      • 8.6.7.3 Saudi Arabia eubiotics market, by form, 2016 - 2027
      • 8.6.7.4 Saudi Arabia eubiotics market, by application, 2016 - 2027
      • 8.6.7.5 Saudi Arabia eubiotics market, by livestock, 2016 - 2027
    • 8.6.8 UAE
      • 8.6.8.1 UAE eubiotics market, 2016 - 2027
      • 8.6.8.2 UAE eubiotics market, by product, 2016 - 2027
      • 8.6.8.3 UAE eubiotics market, by form, 2016 - 2027
      • 8.6.8.4 UAE eubiotics market, by application, 2016 - 2027
      • 8.6.8.5 UAE eubiotics market, by livestock, 2016 - 2027

Chapter 9 Company Profiles

  • 9.1 DSM
    • 9.1.1 Business Overview
    • 9.1.2 Financial Data
    • 9.1.3 Product Landscape
    • 9.1.4 SWOT Analysis
    • 9.1.5 SWOT Analysis
  • 9.2 Novus International
    • 9.2.1 Business Overview
    • 9.2.2 Financial Data
    • 9.2.3 Product Landscape
    • 9.2.4 SWOT Analysis
    • 9.2.5 Strategic Outlook
  • 9.3 BASF SE
    • 9.3.1 Business Overview
    • 9.3.2 Financial Data
    • 9.3.3 Product Landscape
    • 9.3.4 SWOT Analysis
    • 9.3.5 Strategic Outlook
  • 9.4 Beneo GmbH
    • 9.4.1 Business Overview
    • 9.4.2 Financial Data
    • 9.4.3 Product Landscape
    • 9.4.4 SWOT Analysis
  • 9.5 Cargill, Inc.
    • 9.5.1 Business Overview
    • 9.5.2 Financial Data
    • 9.5.3 Product Landscape
    • 9.5.4 SWOT Analysis
    • 9.5.5 Strategic Outlook
  • 9.6 ROQUETTE Freres
    • 9.6.1 Business Overview
    • 9.6.2 Financial Data
    • 9.6.3 Product Landscape
    • 9.6.4 SWOT Analysis
  • 9.7 Novozymes
    • 9.7.1 Business Overview
    • 9.7.2 Financial Data
    • 9.7.3 Product Landscape
    • 9.7.4 SWOT Analysis
    • 9.7.5 Strategic Outlook
  • 9.8 Calpis Co., Ltd.
    • 9.8.1 Business Overview
    • 9.8.2 Financial Data
    • 9.8.3 Product Landscape
    • 9.8.4 SWOT Analysis
  • 9.9 Lesaffre Group
    • 9.9.1 Business Overview
    • 9.9.2 Financial Data
    • 9.9.3 Product Landscape
    • 9.9.4 SWOT Analysis
    • 9.9.5 Strategic Outlook
  • 9.10 Behn Meyer
    • 9.10.1 Business Overview
    • 9.10.2 Financial Data
    • 9.10.3 Product Landscape
    • 9.10.4 SWOT Analysis
  • 9.11 Lallemand, Inc.
    • 9.11.1 Business Overview
    • 9.11.2 Financial Data
    • 9.11.3 Product Landscape
    • 9.11.4 SWOT Analysis
    • 9.11.5 Strategic Outlook
  • 9.12 Friesland Campina
    • 9.12.1 Business Overview
    • 9.12.2 Financial Data
    • 9.12.3 Product Landscape
    • 9.12.4 SWOT Analysis
  • 9.13 Chr. Hansen Holding A/S
    • 9.13.1 Business Overview
    • 9.13.2 Financial Data
    • 9.13.3 Product Landscape
    • 9.13.4 SWOT Analysis
    • 9.13.5 Strategic Outlook
  • 9.14 Neospark
    • 9.14.1 Business Overview
    • 9.14.2 Financial Data
    • 9.14.3 Product Landscape
    • 9.14.4 SWOT Analysis
  • 9.15 Kemin Industries, Inc.
    • 9.15.1 Business Overview
    • 9.15.2 Financial Data
    • 9.15.3 Product Landscape
    • 9.15.4 SWOT Analysis
  • 9.16 BioResource International Inc
    • 9.16.1 Business Overview
    • 9.16.2 Financial Data
    • 9.16.3 Product Landscape
    • 9.16.4 SWOT Analysis
  • 9.17 ABVista
    • 9.17.1 Business Overview
    • 9.17.2 Financial Data
    • 9.17.3 Product Landscape
    • 9.17.4 SWOT Analysis
  • 9.18 Alltech
    • 9.18.1 Business Overview
    • 9.18.2 Financial Data
    • 9.18.3 Product Landscape
    • 9.18.4 SWOT Analysis